Cytokinetics, Incorporated (NASDAQ:CYTK)

Headlines for Cytokinetics, Incorporated

Cytokinetics Presents Non-Clinical Data From Its Smooth Muscle Contractility Program at the 2009 Sci
PR-CANADA.net - 17 hours ago
Cytokinetics, Incorporated ( NASDAQ : CYTK) announced today that three abstracts summarizing non-clinical data regarding its smooth muscle contractility program were presented at the 2009 ...
Cytokinetics (CYTK) Presents Non-Clincial Data Relating to GSK-923295 at AACR-NCI-EORTC Int. Conference
StreetInsider.com - Nov 19, 2009
Cytokinetics, Inc. (NASDAQ: CYTK) announced today that abstracts summarizing non-clinical data relating to GSK-923295, an inhibitor of centromere-associated protein E (CENP-E), were presented at ...
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at the 2009 AACR-NCI-EORTC International Conference
Market Wire - Nov 19, 2009
SOUTH SAN FRANCISCO, CA--(Marketwire - November 19, 2009) - Cytokinetics, Incorporated ( NASDAQ : CYTK) announced today that abstracts summarizing non-clinical data relating to GSK-923295, an ...
Market Report -- In Play (CYTK) - MSN Money
Cytokinetics Announces Presentation Of Non-clinical Data Relating To GSK-923295, An Inhibitor Of CENP-E - Quick Facts - RTT News
Canaccord Adams Initiates Coverage on Cytokinetics (CYTK) with a Buy
StreetInsider.com - Nov 18, 2009
Canaccord analyst says, "CYTK is one of few biotechnology companies developing drugs that directly target muscle function. CYTK was founded on science and technology focused on the intracellular ...